Harbor Investment Advisory’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-200
| Closed | -$6.38K | – | 1175 |
|
|
2024
Q4 | $6.38K | Buy |
+200
| New | +$6.38K | ﹤0.01% | 935 |
|
|
2023
Q3 | – | Sell |
-667
| Closed | -$60.8K | – | 1191 |
|
|
2023
Q2 | $60.8K | Sell |
667
-666
| -50% | -$60.7K | 0.01% | 657 |
|
|
2023
Q1 | $87.9K | Hold |
1,333
| – | – | 0.01% | 534 |
|
|
2022
Q4 | $68.9K | Hold |
1,333
| – | – | 0.01% | 589 |
|
|
2022
Q3 | $91K | Hold |
1,333
| – | – | 0.02% | 496 |
|
|
2022
Q2 | $60K | Buy |
1,333
+220
| +20% | +$9.9K | 0.01% | 644 |
|
|
2022
Q1 | $57K | Sell |
1,113
-154
| -12% | -$7.89K | 0.01% | 710 |
|
|
2021
Q4 | $60K | Buy |
1,267
+254
| +25% | +$12K | 0.01% | 685 |
|
|
2021
Q3 | $33K | Buy |
1,013
+538
| +113% | +$17.5K | ﹤0.01% | 845 |
|
|
2021
Q2 | $30K | Buy |
+475
| New | +$30K | ﹤0.01% | 828 |
|